LENSAR, Inc.(LNSR)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

LENSAR, Inc. (LNSR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LNSR at 53.7/100 on a 32-signal composite quality model, placing it at rank #1,377 of 2,962 stocks — the top half of the AI-ranked universe. LNSR scores in the top quartile across balance sheet strength (99.5), profitability (98.6). Areas of concern include institutional flow (6.4) and revenue scale (10.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 23.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), LENSAR, Inc. reports quarterly revenue of $16.5M, net income of $3.5M. Top institutional holders of LNSR by reported 13-F value include BRANDES INVESTMENT PARTNERS, VANGUARD CAPITAL MANAGEMENT, Groupe la Francaise, based on the most recent SEC filings. LNSR trades on the Nasdaq exchange and files with the SEC under CIK 1320350. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LNSR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for LENSAR, Inc. directly from SEC EDGAR.